Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

Hangzhou Sciwind Biosciences Co., a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases, today announced a licensing and collaboration ...

Gemma Collins has shown off a huge body transformation in the new year, revealing she's already two dress sizes smaller this ...

Gemma Collins has wowed fans with her incredible body transformation in recent months, and has now revealed the 'secret' ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Gemma Collins has revealed that she's using weight loss jabs to help her slim down, but the former TOWIE star is no stranger ...

EXCLUSIVE: Gemma Collins shocked fans by revealing she's taking weight loss injections and has already shrunk by two dress ...

To attract and retain workers, employers will focus on competitive salaries and flexible benefits, experts say.

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...

Sharon Mann has lost nearly 30 pounds since starting on Mounjaro, a GLP-1 medication. Dr. Sanjay Gupta reports.